Wealth Enhancement Advisory Services, LLC Eli Lilly & CO Put Options Transaction History

Wealth Enhancement Advisory Services, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 23, 2024	BUY	$772.14 - $960.02 $772,140 - $960,020	1,000 Added 142.86%	1,700 $1.51 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $724,870 - $909,040	-1,000 Reduced 58.82%	700 $633,000
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $892,823 - $1.05 Million	1,700 New	1,700 $990,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.